{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T21:41:32Z","timestamp":1788471692861,"version":"build-2803163510"},"reference-count":188,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.steroids.2023.109330","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T15:18:40Z","timestamp":1699024720000},"page":"109330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Navigating nonalcoholic fatty liver disease (NAFLD): Exploring the roles of estrogens, pharmacological and medical interventions, and life style"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3288-2672","authenticated-orcid":false,"given":"Qianying","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Hwajin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna Kathryn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashlie","family":"Santaliz-Casiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Madak-Erdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.steroids.2023.109330_b0005","doi-asserted-by":"crossref","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr. Biol."},{"issue":"6391","key":"10.1016\/j.steroids.2023.109330_b0010","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan5931","article-title":"Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells","volume":"360","author":"Ma","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.steroids.2023.109330_b0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.steroids.2014.06.012","article-title":"Estrogen receptors alpha (ER\u03b1) and beta (ER\u03b2): subtype-selective ligands and clinical potential","volume":"90","author":"Paterni","year":"2014","journal-title":"Steroids"},{"issue":"24","key":"10.1016\/j.steroids.2023.109330_b0020","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1007\/s00018-009-0118-z","article-title":"Regulation of estrogen receptor beta activity and implications in health and disease","volume":"66","author":"Swedenborg","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.steroids.2023.109330_b0025","doi-asserted-by":"crossref","unstructured":"P. Walter, et al., Cloning of the human estrogen receptor cDNA. 1985. 82: p. 7889-7893.","DOI":"10.1073\/pnas.82.23.7889"},{"key":"10.1016\/j.steroids.2023.109330_b0030","unstructured":"George, G.J.M.K.a.E.E.a.M.P.-h.a.S.N.a.J.-k.G., Cloning of a novel receptor expressed in rat prostate and ovary. Proceedings of the National Academy of Sciences of the United States of America, 19993 12: p. 5925-30."},{"key":"10.1016\/j.steroids.2023.109330_b0035","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.genm.2008.03.003","article-title":"Estrogen receptors in the kidney: lessons from genetically altered mice","volume":"5 Suppl A","author":"Lane","year":"2008","journal-title":"Gend. Med."},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0040","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.brainresrev.2007.05.013","article-title":"Estrogen receptor beta in the brain: from form to function","volume":"57","author":"Weiser","year":"2008","journal-title":"Brain Res. Rev."},{"issue":"4","key":"10.1016\/j.steroids.2023.109330_b0045","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1124\/pr.58.4.8","article-title":"International Union of Pharmacology. LXIV. Estrogen Receptors","volume":"58","author":"Dahlman-Wright","year":"2006","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0050","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1152\/physrev.00026.2006","article-title":"Estrogen receptors: how do they signal and what are their targets","volume":"87","author":"Heldring","year":"2007","journal-title":"Physiol. Rev."},{"issue":"10","key":"10.1016\/j.steroids.2023.109330_b0055","doi-asserted-by":"crossref","first-page":"4831","DOI":"10.1210\/en.2006-0563","article-title":"Impact of estrogen receptor beta on gene networks regulated by estrogen receptor alpha in breast cancer cells","volume":"147","author":"Chang","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2023.109330_b0060","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1016\/j.breast.2015.07.015","article-title":"The changing role of ER in endocrine resistance","volume":"24 Suppl 2(0 2)","author":"Nardone","year":"2015","journal-title":"Breast"},{"issue":"4","key":"10.1016\/j.steroids.2023.109330_b0065","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1210\/endrev\/bnab041","article-title":"Membrane-Initiated Estrogen, Androgen, and Progesterone Receptor Signaling in Health and Disease","volume":"43","author":"Mauvais-Jarvis","year":"2022","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.tem.2018.10.006","article-title":"Crosstalk between Estrogen Signaling and Breast Cancer Metabolism","volume":"30","author":"Kulkoyluoglu-Cotul","year":"2019","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0075","doi-asserted-by":"crossref","first-page":"G582","DOI":"10.1152\/ajpgi.00374.2006","article-title":"Does estrogen contribute to the hepatic regeneration following portal branch ligation in rats?","volume":"292","author":"Kawai","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"23","key":"10.1016\/j.steroids.2023.109330_b0080","doi-asserted-by":"crossref","first-page":"12735","DOI":"10.1073\/pnas.97.23.12735","article-title":"Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity","volume":"97","author":"Jones","year":"2000","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.steroids.2023.109330_b0085","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1172\/JCI9575","article-title":"Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice","volume":"105","author":"Nemoto","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.steroids.2023.109330_b0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.fct.2018.05.006","article-title":"Effects of high fructose intake on liver injury progression in high fat diet induced fatty liver disease in ovariectomized female mice","volume":"118","author":"Ohashi","year":"2018","journal-title":"Food Chem. Toxicol."},{"issue":"37","key":"10.1016\/j.steroids.2023.109330_b0095","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.3748\/wjg.v23.i37.6802","article-title":"Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis","volume":"23","author":"Iyer","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"10.1016\/j.steroids.2023.109330_b0100","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.metabol.2016.01.012","article-title":"Epidemiology and natural history of non-alcoholic fatty liver disease","volume":"65","author":"Fazel","year":"2016","journal-title":"Metabolism"},{"issue":"47","key":"10.1016\/j.steroids.2023.109330_b0105","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.3748\/wjg.v23.i47.8263","article-title":"Clinical epidemiology and disease burden of nonalcoholic fatty liver disease","volume":"23","author":"Perumpail","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"6037","key":"10.1016\/j.steroids.2023.109330_b0110","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.steroids.2023.109330_b0115","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0120","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.steroids.2023.109330_b0125","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00125-005-1682-x","article-title":"Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms","volume":"48","author":"Bugianesi","year":"2005","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.steroids.2023.109330_b0130","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/hep4.1353","article-title":"Insulin Resistance Exacerbates Genetic Predisposition to Nonalcoholic Fatty Liver Disease in Individuals Without Diabetes","volume":"3","author":"Barata","year":"2019","journal-title":"Hepatol Commun"},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020991","article-title":"Inulin Improves Diet-Induced Hepatic Steatosis and Increases Intestinal Akkermansia Genus Level","volume":"23","author":"Perez-Monter","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.steroids.2023.109330_b0140","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/j.dld.2021.07.009","article-title":"Genetic predisposition, lifestyle risk, and obesity associate with the progression of nonalcoholic fatty liver disease","volume":"53","author":"Liu","year":"2021","journal-title":"Dig. Liver Dis."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ncp.10449","article-title":"Evolution of NAFLD and Its Management","volume":"35","author":"Mundi","year":"2020","journal-title":"Nutr. Clin. Pract."},{"issue":"4","key":"10.1016\/j.steroids.2023.109330_b0150","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/hep.26761","article-title":"Gender and menopause impact severity of fibrosis among patients with nonalcoholic steatohepatitis","volume":"59","author":"Yang","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.steroids.2023.109330_b0155","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.cgh.2017.05.036","article-title":"Estrogen Replacement Reduces Risk and Increases Survival Times of Women With Hepatocellular Carcinoma","volume":"15","author":"Hassan","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"15","key":"10.1016\/j.steroids.2023.109330_b0160","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1113\/JP277270","article-title":"Anti-inflammatory effects of oestrogen mediate the sexual dimorphic response to lipid-induced insulin resistance","volume":"597","author":"Camporez","year":"2019","journal-title":"J. Physiol."},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0165","doi-asserted-by":"crossref","first-page":"e0151455","DOI":"10.1371\/journal.pone.0151455","article-title":"Estradiol and Estrogen Receptor Agonists Oppose Oncogenic Actions of Leptin in HepG2 Cells","volume":"11","author":"Shen","year":"2016","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.steroids.2023.109330_b0170","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1080\/15592294.2020.1770917","article-title":"Estrogen-induced epigenetic silencing of FTH1 and TFRC genes reduces liver cancer cell growth and survival","volume":"15","author":"Muhammad","year":"2020","journal-title":"Epigenetics"},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0175","doi-asserted-by":"crossref","first-page":"p. 256-+","DOI":"10.1016\/j.cmet.2018.05.021","article-title":"Short-Term Fasting Reveals Amino Acid Metabolism as a Major Sex-Discriminating Factor in the Liver","volume":"28","author":"Della Torre","year":"2018","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.steroids.2023.109330_b0180","doi-asserted-by":"crossref","first-page":"E1188","DOI":"10.1152\/ajpendo.00579.2013","article-title":"Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity","volume":"306","author":"Zhu","year":"2014","journal-title":"American Journal of Physiology-Endocrinology and Metabolism"},{"key":"10.1016\/j.steroids.2023.109330_b0185","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13571-x","article-title":"Sexual dimorphism and the role of estrogen in the immune microenvironment of liver metastases","volume":"10","author":"Milette","year":"2019","journal-title":"Nature Commun."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0190","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hep.28514","article-title":"A Longer Duration of Estrogen Deficiency Increases Fibrosis Risk Among Postmenopausal Women With Nonalcoholic Fatty Liver Disease","volume":"64","author":"Klair","year":"2016","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.steroids.2023.109330_b0195","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/ijo.2017.50","article-title":"Hormone signaling and fatty liver in females: analysis of estrogen receptor alpha mutant mice","volume":"41","author":"Hart-Unger","year":"2017","journal-title":"Int. J. Obes. (Lond)"},{"issue":"10","key":"10.1016\/j.steroids.2023.109330_b0200","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1016\/j.celrep.2018.02.041","article-title":"Estrogen Deficiency Promotes Hepatic Steatosis via a Glucocorticoid Receptor-Dependent Mechanism in Mice","volume":"22","author":"Quinn","year":"2018","journal-title":"Cell Rep."},{"issue":"10","key":"10.1016\/j.steroids.2023.109330_b0205","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.7150\/thno.23624","article-title":"Estrogen receptors orchestrate cell growth and differentiation to facilitate liver regeneration","volume":"8","author":"Kao","year":"2018","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.steroids.2023.109330_b0210","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1053\/j.gastro.2019.01.010","article-title":"Estrogen Activation of G-Protein-Coupled Estrogen Receptor 1 Regulates Phosphoinositide 3-Kinase and mTOR Signaling to Promote Liver Growth in Zebrafish and Proliferation of Human Hepatocytes","volume":"156","author":"Chaturantabut","year":"2019","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.steroids.2023.109330_b0215","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20153709","article-title":"Estrogen Deficiency Potentiates Thioacetamide-Induced Hepatic Fibrosis in Sprague-Dawley Rats","volume":"20","author":"Lee","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0220","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/j.gastro.2016.09.017","article-title":"Estrogen signals through peroxisome proliferator-activated Receptor\u2212 \u03b3 coactivator 1\u03b1 to reduce oxidative damage associated with diet-induced fatty liver disease","volume":"152","author":"Besse-Patin","year":"2017","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.steroids.2023.109330_b0225","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101259","article-title":"Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease\/Nonalcoholic Steatohepatitis","volume":"8","author":"Lee","year":"2019","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.steroids.2023.109330_b0230","doi-asserted-by":"crossref","DOI":"10.3390\/nu13103334","article-title":"Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets","volume":"13","author":"Zuo","year":"2021","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0235","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.physbeh.2009.02.017","article-title":"Sex differences in the regulation of body weight","volume":"97","author":"Shi","year":"2009","journal-title":"Physiol. Behav."},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0240","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/157339912799424573","article-title":"Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review","volume":"8","author":"Saad","year":"2012","journal-title":"Curr. Diabetes Rev."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0245","first-page":"239","article-title":"Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens","volume":"80","author":"Marin","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7680","key":"10.1016\/j.steroids.2023.109330_b0250","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature24302","article-title":"Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity","volume":"551","author":"Shalapour","year":"2017","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.steroids.2023.109330_b0255","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0260","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.25634","article-title":"I148M PNPLA3 variant and progressive liver disease: a new paradigm in hepatology","volume":"56","author":"Valenti","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3350\/cmh.2016.0109","article-title":"Genetic predisposition in nonalcoholic fatty liver disease","volume":"23","author":"Sookoian","year":"2017","journal-title":"Clin. Mol. Hepatol."},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0270","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/gut.2009.190801","article-title":"Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease","volume":"59","author":"Dongiovanni","year":"2010","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0275","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jhep.2010.05.023","article-title":"Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease","volume":"53","author":"Valenti","year":"2010","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0280","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jhep.2011.05.029","article-title":"The SOD2 C47T polymorphism influences NAFLD fibrosis severity: evidence from case-control and intra-familial allele association studies","volume":"56","author":"Al-Serri","year":"2012","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0285","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2008.04.004","article-title":"The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver disease","volume":"135","author":"Miele","year":"2008","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0290","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cld.1007","article-title":"The Role of Life Style Modifications in Comprehensive Non-Alcoholic Fatty Liver Disease Treatment","volume":"17","author":"Viveiros","year":"2021","journal-title":"Clin. Liver Dis. (hoboken)"},{"issue":"23","key":"10.1016\/j.steroids.2023.109330_b0295","doi-asserted-by":"crossref","first-page":"e2100381","DOI":"10.1002\/mnfr.202100381","article-title":"Improvement of Non-Alcoholic Fatty Liver Disease in Mice by Intermittent Use of a Fasting-Mimicking Diet","volume":"65","author":"Zhao","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"issue":"6","key":"10.1016\/j.steroids.2023.109330_b0300","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jhepr.2019.10.008","article-title":"Lifestyle modification in NAFLD\/NASH: Facts and figures","volume":"1","author":"Hallsworth","year":"2019","journal-title":"JHEP Rep"},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0305","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3350\/cmh.2021.0178","article-title":"KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease","volume":"27","author":"Kang","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"issue":"7","key":"10.1016\/j.steroids.2023.109330_b0310","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s00125-017-4264-9","article-title":"EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease in severely obese people: do they lead to over-referral?","volume":"60","author":"Blond","year":"2017","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0315","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2013.04.013","article-title":"Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"59","author":"Wong","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.steroids.2023.109330_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.08.071","article-title":"The effect of coffee consumption on the non-alcoholic fatty liver disease and liver fibrosis: A meta-analysis of 11 epidemiological studies","volume":"20","author":"Hayat","year":"2021","journal-title":"Ann. Hepatol."},{"issue":"6","key":"10.1016\/j.steroids.2023.109330_b0325","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1742-7843.2008.00231.x","article-title":"Caffeine inhibits the proliferation of liver cancer cells and activates the MEK\/ERK\/EGFR signalling pathway","volume":"102","author":"Okano","year":"2008","journal-title":"Basic Clin. Paharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0330","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3346\/jkms.2017.32.1.60","article-title":"Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness","volume":"32","author":"Lee","year":"2017","journal-title":"J. Korean Med. Sci."},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0335","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator\u2212 activated receptor\u2212 \u03b1 and\u2212 \u03b4, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.steroids.2023.109330_b0340","article-title":"miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular Disease","volume":"7","author":"Lopez-Pastor","year":"2020","journal-title":"Front. Med. (lausanne)"},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0345","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4254\/wjh.v7.i2.226","article-title":"Micro RNAs in the development of non-alcoholic fatty liver disease","volume":"7","author":"Gerhard","year":"2015","journal-title":"World J. Hepatol."},{"issue":"4","key":"10.1016\/j.steroids.2023.109330_b0350","doi-asserted-by":"crossref","DOI":"10.3390\/cells9041041","article-title":"The Emerging Role of MicroRNAs in NAFLD: Highlight of MicroRNA-29a in Modulating Oxidative Stress, Inflammation, and Beyond","volume":"9","author":"Lin","year":"2020","journal-title":"Cells"},{"issue":"14","key":"10.1016\/j.steroids.2023.109330_b0355","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22147571","article-title":"Current Options and Future Directions for NAFLD and NASH Treatment","volume":"22","author":"Zhang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.steroids.2023.109330_b0360","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/HMER.S265631","article-title":"Efficacy of Glucagon-Like Peptide-1 Analogs in Nonalcoholic Fatty Liver Disease: A Systematic Review","volume":"12","author":"Teshome","year":"2020","journal-title":"Hepat. Med."},{"key":"10.1016\/j.steroids.2023.109330_b0365","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.phrs.2018.09.025","article-title":"Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)","volume":"137","author":"Bifari","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"10019","key":"10.1016\/j.steroids.2023.109330_b0370","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"issue":"9972","key":"10.1016\/j.steroids.2023.109330_b0375","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0380","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2021.01.047","article-title":"A structurally optimized FXR agonist, MET409, reduced liver fat content over 12 weeks in patients with non-alcoholic steatohepatitis","volume":"75","author":"Harrison","year":"2021","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0385","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2021.10.018","article-title":"EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study","volume":"76","author":"Ratziu","year":"2022","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0390","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/13543784.2020.1718106","article-title":"Targeting CCR2\/5 in the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis: opportunities and challenges","volume":"29","author":"Lefere","year":"2020","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"6","key":"10.1016\/j.steroids.2023.109330_b0395","doi-asserted-by":"crossref","first-page":"e0158156","DOI":"10.1371\/journal.pone.0158156","article-title":"Antifibrotic Effects of the Dual CCR2\/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis","volume":"11","author":"Lefebvre","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0400","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","article-title":"Gut microbiome, liver immunology, and liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0405","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1159\/000495830","article-title":"Microbial intervention as a novel target in treatment of non-alcoholic fatty liver disease progression","volume":"51","author":"Zhou","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"issue":"6","key":"10.1016\/j.steroids.2023.109330_b0410","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/07315724.2015.1031355","article-title":"Effects of Multistrain Probiotic Supplementation on Glycemic and Inflammatory Indices in Patients with Nonalcoholic Fatty Liver Disease: A Double-Blind Randomized Clinical Trial","volume":"35","author":"Sepideh","year":"2016","journal-title":"J. Am. Coll. Nutr."},{"issue":"6","key":"10.1016\/j.steroids.2023.109330_b0415","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jhep.2008.01.035","article-title":"Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin","volume":"48","author":"Bergheim","year":"2008","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.steroids.2023.109330_b0420","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1097\/MEG.0000000000000348","article-title":"Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease","volume":"27","author":"Gangarapu","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0425","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cct.2008.09.003","article-title":"Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design","volume":"30","author":"Chalasani","year":"2009","journal-title":"Contemp. Clin. Trials"},{"issue":"9","key":"10.1016\/j.steroids.2023.109330_b0430","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1369\/0022155420946402","article-title":"4-HNE immunohistochemistry and image analysis for detection of lipid peroxidation in human liver samples using vitamin E treatment in NAFLD as a proof of concept","volume":"68","author":"Podszun","year":"2020","journal-title":"J. Histochem. Cytochem."},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0435","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3748\/wjg.v18.i5.401","article-title":"Update of endoscopy in liver disease: more than just treating varices","volume":"18","author":"Krystallis","year":"2012","journal-title":"World J Gastroenterol: WJG"},{"issue":"9","key":"10.1016\/j.steroids.2023.109330_b0440","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/liv.14917","article-title":"Effects of intragastric balloon in patients with nonalcoholic fatty liver disease and advanced fibrosis","volume":"41","author":"Salomone","year":"2021","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.steroids.2023.109330_b0445","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s12664-021-01202-7","article-title":"Endoscopic sleeve gastroplasty - minimally invasive treatment for non-alcoholic fatty liver disease and obesity","volume":"40","author":"Jagtap","year":"2021","journal-title":"Indian J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0450","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1186\/s13063-021-05695-7","article-title":"Efficacy and safety of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy in obese subjects with Non-Alcoholic SteatoHepatitis (NASH): study protocol for a randomized controlled trial (TESLA-NASH study)","volume":"22","author":"Lavin-Alconero","year":"2021","journal-title":"Trials"},{"issue":"28","key":"10.1016\/j.steroids.2023.109330_b0455","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.3748\/wjg.v24.i28.3112","article-title":"Considerations for bariatric surgery in patients with cirrhosis","volume":"24","author":"Goh","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.steroids.2023.109330_b0460","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1055\/s-0041-1731705","article-title":"Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases","volume":"41","author":"Mendoza","year":"2021","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"10.1016\/j.steroids.2023.109330_b0465","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11695-007-9086-2","article-title":"Resolution of nonalcoholic steatohepatits after gastric bypass surgery","volume":"17","author":"Liu","year":"2007","journal-title":"Obes. Surg."},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0470","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/jjco\/hyx180","article-title":"Chemotherapy for hepatocellular carcinoma: current status and future perspectives","volume":"48","author":"Ikeda","year":"2018","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.steroids.2023.109330_b0475","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1245\/s10434-010-1148-3","article-title":"Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial","volume":"17","author":"Xia","year":"2010","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0480","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States","volume":"19","author":"Younossi","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"21","key":"10.1016\/j.steroids.2023.109330_b0485","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.3748\/wjg.v25.i21.2591","article-title":"Liver transplantation for hepatocellular carcinoma: Where do we stand?","volume":"25","author":"Santopaolo","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0490","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2012.10.005","article-title":"Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis","volume":"144","author":"Singh","year":"2013","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0495","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/ajg.2010.475","article-title":"Statin use and the risk of liver cancer: a population-based case\u2013control study","volume":"106","author":"Chiu","year":"2011","journal-title":"Official Journal of the American College of Gastroenterology| ACG"},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0500","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jhep.2017.10.018","article-title":"Statin use and the risk of hepatocellular carcinoma in patients at high risk: a nationwide nested case-control study","volume":"68","author":"Kim","year":"2018","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0505","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/ijc.32426","article-title":"Statin use and risk of liver cancer: evidence from two population-based studies","volume":"146","author":"Tran","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.steroids.2023.109330_b0510","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12935-016-0351-0","article-title":"The chimeric multi-domain proteins mediating specific DNA transfer for hepatocellular carcinoma treatment","volume":"16","author":"Yang","year":"2016","journal-title":"Cancer Cell Int."},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0515","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/1878-0261.12479","article-title":"The fusion landscape of hepatocellular carcinoma","volume":"13","author":"Zhu","year":"2019","journal-title":"Mol. Oncol."},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0520","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41389-021-00320-3","article-title":"C20orf204, a hepatocellular carcinoma-specific protein interacts with nucleolin and promotes cell proliferation","volume":"10","author":"Burbano De Lara","year":"2021","journal-title":"Oncogenesis"},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0525","doi-asserted-by":"crossref","first-page":"e0263931","DOI":"10.1371\/journal.pone.0263931","article-title":"Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis","volume":"17","author":"Fernandez","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.steroids.2023.109330_b0530","doi-asserted-by":"crossref","DOI":"10.1111\/liv.15209","article-title":"Knowledge of liver fibrosis stage among adults with NAFLD\/NASH improves adherence to lifestyle changes","author":"Carrieri","year":"2022","journal-title":"Liver Int."},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0535","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1055\/s-0041-1729971","article-title":"Dietary Treatment for NAFLD: New Clinical and Epidemiological Evidence and Updated Recommendations","volume":"41","author":"Zelber-Sagi","year":"2021","journal-title":"Semin. Liver Dis."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0540","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/hep4.1707","article-title":"Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data","volume":"6","author":"Paik","year":"2022","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0545","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.cgh.2016.07.031","article-title":"Exercise Reduces Liver Lipids and Visceral Adiposity in Patients With Nonalcoholic Steatohepatitis in a Randomized Controlled Trial","volume":"15","author":"Houghton","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.steroids.2023.109330_b0550","doi-asserted-by":"crossref","DOI":"10.3390\/nu9080800","article-title":"Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease","volume":"9","author":"Eslamparast","year":"2017","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0555","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.clnu.2014.01.018","article-title":"Mediterranean diet and non-alcoholic fatty liver disease: the need of extended and comprehensive interventions","volume":"34","author":"Trovato","year":"2015","journal-title":"Clin. Nutr."},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0560","doi-asserted-by":"crossref","DOI":"10.3390\/nu14020258","article-title":"Mediterranean Diet and Fatty Liver Risk in a Population of Overweight Older Italians: A Propensity Score-Matched Case-Cohort Study","volume":"14","author":"Lampignano","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.steroids.2023.109330_b0565","first-page":"1","article-title":"The effect of a Mediterranean diet vs. a low-fat diet on non-alcoholic fatty liver disease in children: a randomized trial","author":"Akbulut","year":"2021","journal-title":"Int. J. Food Sci. Nutr."},{"issue":"4","key":"10.1016\/j.steroids.2023.109330_b0570","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/liv.12990","article-title":"The effects of DASH diet on weight loss and metabolic status in adults with non-alcoholic fatty liver disease: a randomized clinical trial","volume":"36","author":"Razavi Zade","year":"2016","journal-title":"Liver Int."},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0575","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3945\/an.116.013730","article-title":"Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease","volume":"8","author":"Hsu","year":"2017","journal-title":"Adv. Nutr."},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0580","doi-asserted-by":"crossref","first-page":"E22","DOI":"10.1111\/hepr.12918","article-title":"Comparison of efficacy of low-carbohydrate and low-fat diet education programs in non-alcoholic fatty liver disease: A randomized controlled study","volume":"48","author":"Jang","year":"2018","journal-title":"Hepatol. Res."},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0585","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2009.01.048","article-title":"Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction","volume":"136","author":"Kirk","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0590","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10620-006-9433-5","article-title":"The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study","volume":"52","author":"Tendler","year":"2007","journal-title":"Dig. Dis. Sci."},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0595","first-page":"730","article-title":"Effect of two different hypocaloric diets in transaminases and insulin resistance in nonalcoholic fatty liver disease and obese patients","volume":"25","author":"de Luis","year":"2010","journal-title":"Nutr. Hosp."},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0600","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/sj.ejcn.1602127","article-title":"Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study","volume":"59","author":"Daubioul","year":"2005","journal-title":"Eur. J. Clin. Nutr."},{"issue":"11","key":"10.1016\/j.steroids.2023.109330_b0605","doi-asserted-by":"crossref","first-page":"e13316","DOI":"10.1111\/obr.13316","article-title":"Dietary fiber-derived short-chain fatty acids: A potential therapeutic target to alleviate obesity-related nonalcoholic fatty liver disease","volume":"22","author":"Zhang","year":"2021","journal-title":"Obes. Rev."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0610","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jhep.2014.08.036","article-title":"Effects of n-3 fish oil on metabolic and histological parameters in NASH: a double-blind, randomized, placebo-controlled trial","volume":"62","author":"Argo","year":"2015","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.steroids.2023.109330_b0615","doi-asserted-by":"crossref","DOI":"10.3390\/nu12113372","article-title":"Impact of Long-Term Supplementation with Fish Oil in Individuals with Non-Alcoholic Fatty Liver Disease: A Double Blind Randomized Placebo Controlled Clinical Trial","volume":"12","author":"Cansancao","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0620","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.clnu.2015.05.001","article-title":"Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial","volume":"35","author":"Nogueira","year":"2016","journal-title":"Clin. Nutr."},{"key":"10.1016\/j.steroids.2023.109330_b0625","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.semcdb.2020.11.011","article-title":"Pubertal mammary gland development is a key determinant of adult mammographic density","volume":"114","author":"Ghadge","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.steroids.2023.109330_b0630","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41366-018-0224-9","article-title":"High-fat diet consumption alters energy metabolism in the mouse hypothalamus","volume":"43","author":"Lizarbe","year":"2019","journal-title":"Int. J. Obes. (Lond)"},{"issue":"40","key":"10.1016\/j.steroids.2023.109330_b0635","doi-asserted-by":"crossref","first-page":"8905","DOI":"10.3748\/wjg.v22.i40.8905","article-title":"Effects of a high fat diet on intestinal microbiota and gastrointestinal diseases","volume":"22","author":"Zhang","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.steroids.2023.109330_b0640","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/j.pain.0000000000001259","article-title":"High-fat diet exacerbates postoperative pain and inflammation in a sex-dependent manner","volume":"159","author":"Song","year":"2018","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.steroids.2023.109330_b0645","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.trecan.2021.06.005","article-title":"High-Fat Diet Impacts on Tumor Development in the Gut","volume":"7","author":"van Driel","year":"2021","journal-title":"Trends Cancer"},{"key":"10.1016\/j.steroids.2023.109330_b0650","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.redox.2016.01.009","article-title":"Effects of high fat diets on rodent liver bioenergetics and oxidative imbalance","volume":"8","author":"Kakimoto","year":"2016","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0655","doi-asserted-by":"crossref","DOI":"10.3390\/nu10030365","article-title":"The Western Diet-Microbiome-Host Interaction and Its Role in Metabolic Disease","volume":"10","author":"Zinocker","year":"2018","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0660","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/oby.22436","article-title":"Mediterranean versus Western Diet Effects on Caloric Intake, Obesity, Metabolism, and Hepatosteatosis in Nonhuman Primates","volume":"27","author":"Shively","year":"2019","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0665","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.bbadis.2016.05.025","article-title":"Western-style diet, sex steroids and metabolism","volume":"1863","author":"Varlamov","year":"2017","journal-title":"Biochim. Biophys. Acta Mol. basis Dis."},{"key":"10.1016\/j.steroids.2023.109330_b0670","doi-asserted-by":"crossref","unstructured":"A. Jeznach-Steinhagen et al. Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease 55 2019 Medicina (Kaunas).","DOI":"10.3390\/medicina55050166"},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0675","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jhep.2008.03.018","article-title":"Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats","volume":"49","author":"Wei","year":"2008","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0680","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/gutjnl-2015-309600","article-title":"Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis","volume":"66","author":"Klein","year":"2017","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0685","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.27117","article-title":"Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis","volume":"60","author":"Granzow","year":"2014","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0690","doi-asserted-by":"crossref","first-page":"11598","DOI":"10.1038\/s41598-019-48024-4","article-title":"TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor","volume":"9","author":"Klein","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0695","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1038\/s41598-020-61473-6","article-title":"Western diet induces severe nonalcoholic steatohepatitis, ductular reaction, and hepatic fibrosis in liver CGI-58 knockout mice","volume":"10","author":"Yang","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.steroids.2023.109330_b0700","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.dld.2012.12.006","article-title":"PNPLA3 I148M variant and hepatocellular carcinoma: a common genetic variant for a rare disease","volume":"45","author":"Valenti","year":"2013","journal-title":"Dig. Liver Dis."},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0705","doi-asserted-by":"crossref","first-page":"e1001324","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits","volume":"7","author":"Speliotes","year":"2011","journal-title":"PLoS Genet."},{"issue":"4","key":"10.1016\/j.steroids.2023.109330_b0710","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.steroids.2023.109330_b0715","doi-asserted-by":"crossref","first-page":"9139","DOI":"10.3390\/nu7115459","article-title":"Definition of the Mediterranean Diet; a Literature Review","volume":"7","author":"Davis","year":"2015","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0720","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/00008469-200410000-00014","article-title":"Mediterranean diet and longevity","volume":"13","author":"Trichopoulou","year":"2004","journal-title":"Eur. J. Cancer Prev."},{"issue":"9","key":"10.1016\/j.steroids.2023.109330_b0725","doi-asserted-by":"crossref","DOI":"10.3390\/nu11092059","article-title":"Cancer and Mediterranean Diet: A Review","volume":"11","author":"Mentella","year":"2019","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.steroids.2023.109330_b0730","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.biopha.2006.07.080","article-title":"Evolutionary aspects of diet, the omega-6\/omega-3 ratio and genetic variation: nutritional implications for chronic diseases","volume":"60","author":"Simopoulos","year":"2006","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.steroids.2023.109330_b0735","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/bph.14778","article-title":"Mediterranean diet and health status: Active ingredients and pharmacological mechanisms","volume":"177","author":"Schwingshackl","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0740","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.18632\/oncotarget.13553","article-title":"Impact of Mediterranean diet on metabolic syndrome, cancer and longevity","volume":"8","author":"Di Daniele","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.steroids.2023.109330_b0745","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s001250100009","article-title":"A Mediterranean and a high-carbohydrate diet improve glucose metabolism in healthy young persons","volume":"44","author":"Perez-Jimenez","year":"2001","journal-title":"Diabetologia"},{"issue":"377","key":"10.1016\/j.steroids.2023.109330_b0750","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai8700","article-title":"Fasting-mimicking diet and markers\/risk factors for aging, diabetes, cancer, and cardiovascular disease","volume":"9","author":"Wei","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"Supplement_4","key":"10.1016\/j.steroids.2023.109330_b0755","first-page":"S340","article-title":"Protein quantity and source, fasting-mimicking diets, and longevity. Advances","volume":"10","author":"Brandhorst","year":"2019","journal-title":"Nutrition"},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0760","doi-asserted-by":"crossref","first-page":"11232","DOI":"10.1038\/s41598-019-47763-8","article-title":"A Randomised Controlled Trial on the Effectiveness and Adherence of Modified Alternate-day Calorie Restriction in Improving Activity of Non-Alcoholic Fatty Liver Disease","volume":"9","author":"Johari","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0765","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.jhep.2019.01.026","article-title":"Autophagy in liver diseases: Time for translation?","volume":"70","author":"Allaire","year":"2019","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0770","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-019-08829-3","article-title":"Autophagy regulates lipid metabolism through selective turnover of NCoR1","volume":"10","author":"Saito","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.steroids.2023.109330_b0775","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molmet.2019.06.026","article-title":"Ketogenic diet in the treatment of cancer\u2013where do we stand?","volume":"33","author":"Weber","year":"2020","journal-title":"Molecular Metabolism"},{"issue":"8","key":"10.1016\/j.steroids.2023.109330_b0780","first-page":"e9639","article-title":"Advantages and Disadvantages of the Ketogenic Diet: A Review Article","volume":"12","author":"Batch","year":"2020","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0785","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/WCO.0000000000000432","article-title":"New insights into the mechanisms of the ketogenic diet","volume":"30","author":"Boison","year":"2017","journal-title":"Curr. Opin. Neurol."},{"issue":"4","key":"10.1016\/j.steroids.2023.109330_b0790","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4103\/jpgm.JPGM_16_17","article-title":"Ketogenic diet in endocrine disorders: Current perspectives","volume":"63","author":"Gupta","year":"2017","journal-title":"J. Postgrad. Med."},{"issue":"6","key":"10.1016\/j.steroids.2023.109330_b0795","doi-asserted-by":"crossref","first-page":"G956","DOI":"10.1152\/ajpgi.00539.2010","article-title":"Hepatic steatosis, inflammation, and ER stress in mice maintained long term on a very low-carbohydrate ketogenic diet","volume":"300","author":"Garbow","year":"2011","journal-title":"American Journal of Physiology-Gastrointestinal and Liver Physiology"},{"issue":"Supplement_1","key":"10.1016\/j.steroids.2023.109330_b0800","doi-asserted-by":"crossref","DOI":"10.2337\/db18-1884-P","article-title":"Sex differences in the response of C57BL\/6 mice to ketogenic diets","volume":"67","author":"Cochran","year":"2018","journal-title":"Diabetes"},{"issue":"13","key":"10.1016\/j.steroids.2023.109330_b0805","article-title":"Targeting metabolic vulnerabilities of endocrine resistant breast cancers using XPO1 and NAMPT inhibition","volume":"81","author":"Zuo","year":"2021","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.steroids.2023.109330_b0810","doi-asserted-by":"crossref","DOI":"10.3390\/diseases5040023","article-title":"An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease","volume":"5","author":"Perumpail","year":"2017","journal-title":"Diseases"},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0815","doi-asserted-by":"crossref","first-page":"359","DOI":"10.15403\/jgld.2014.1121.243.gta","article-title":"Hype or reality: should patients with metabolic syndrome-related NAFLD be on the hunter-gatherer (Paleo) diet to decrease morbidity","volume":"24","author":"Tarantino","year":"2015","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"10.1016\/j.steroids.2023.109330_b0820","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nut.2017.02.008","article-title":"Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study","volume":"39\u201340","author":"Della Corte","year":"2017","journal-title":"Nutrition"},{"key":"10.1016\/j.steroids.2023.109330_b0825","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/1476-511X-13-160","article-title":"Favourable effects of consuming a Palaeolithic-type diet on characteristics of the metabolic syndrome: a randomized controlled pilot-study","volume":"13","author":"Boers","year":"2014","journal-title":"Lipids Health Dis."},{"issue":"12","key":"10.1016\/j.steroids.2023.109330_b0830","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/ejcn.2015.193","article-title":"Metabolic and physiologic improvements from consuming a paleolithic, hunter-gatherer type diet","volume":"69","author":"Frassetto","year":"2015","journal-title":"Eur. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0835","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/ijo.2016.4","article-title":"Strong and persistent effect on liver fat with a Paleolithic diet during a two-year intervention","volume":"40","author":"Otten","year":"2016","journal-title":"Int. J. Obes. (Lond)"},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0840","doi-asserted-by":"crossref","DOI":"10.15403\/jgld-3064","article-title":"Vegan Diet Advice Might Benefit Liver Enzymes in Nonalcoholic Fatty Liver Disease: an Open Observational Pilot Study","volume":"30","author":"Chiarioni","year":"2021","journal-title":"J. Gastrointestin. Liver Dis."},{"issue":"8","key":"10.1016\/j.steroids.2023.109330_b0845","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2337\/dc06-0606","article-title":"A low-fat vegan diet improves glycemic control and cardiovascular risk factors in a randomized clinical trial in individuals with type 2 diabetes","volume":"29","author":"Barnard","year":"2006","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.steroids.2023.109330_b0850","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.amjmed.2005.03.039","article-title":"The effects of a low-fat, plant-based dietary intervention on body weight, metabolism, and insulin sensitivity","volume":"118","author":"Barnard","year":"2005","journal-title":"Am. J. Med."},{"issue":"45","key":"10.1016\/j.steroids.2023.109330_b0855","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.3748\/wjg.v24.i45.5095","article-title":"Effects of alkaline-electrolyzed and hydrogen-rich water, in a high-fat-diet nonalcoholic fatty liver disease mouse model","volume":"24","author":"Jackson","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0860","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/jn\/nxab401","article-title":"A High-Fat Western Diet Attenuates Intestinal Changes in Mice with DSS-Induced Low-Grade Inflammation","volume":"152","author":"Papoutsis","year":"2022","journal-title":"J. Nutr."},{"issue":"7","key":"10.1016\/j.steroids.2023.109330_b0865","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.3390\/nu11071602","article-title":"Western diet-induced metabolic alterations affect circulating markers of liver function before the development of steatosis","volume":"11","author":"Gabbia","year":"2019","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.steroids.2023.109330_b0870","doi-asserted-by":"crossref","first-page":"E1724","DOI":"10.1152\/ajpendo.00717.2006","article-title":"A high-fat, ketogenic diet induces a unique metabolic state in mice","volume":"292","author":"Kennedy","year":"2007","journal-title":"Am. J. Phys. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0875","first-page":"e6605","article-title":"Ketogenic Diet-induced Elevated Cholesterol, Elevated Liver Enzymes and Potential Non-alcoholic Fatty Liver Disease","volume":"12","author":"Anekwe","year":"2020","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0880","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1007\/s11695-020-05202-y","article-title":"Effect of Fasting-Mimicking Diet or Continuous Energy Restriction on Weight Loss, Body Composition, and Appetite-Regulating Hormones Among Metabolically Healthy Women with Obesity: a Randomized Controlled, Parallel Trial","volume":"31","author":"Sadeghian","year":"2021","journal-title":"Obes. Surg."},{"issue":"2","key":"10.1016\/j.steroids.2023.109330_b0885","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ijo.2017.206","article-title":"Intermittent energy restriction improves weight loss efficiency in obese men: the MATADOR study","volume":"42","author":"Byrne","year":"2018","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.steroids.2023.109330_b0890","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12986-018-0318-3","article-title":"Intermittent administration of a fasting-mimicking diet intervenes in diabetes progression, restores beta cells and reconstructs gut microbiota in mice","volume":"15","author":"Wei","year":"2018","journal-title":"Nutr. Metab. (Lond.)"},{"issue":"5","key":"10.1016\/j.steroids.2023.109330_b0895","doi-asserted-by":"crossref","DOI":"10.3390\/nu14051093","article-title":"Fasting-Mimicking Diet Reduces Trimethylamine N-Oxide Levels and Improves Serum Biochemical Parameters in Healthy Volunteers","volume":"14","author":"Videja","year":"2022","journal-title":"Nutrients"},{"issue":"23","key":"10.1016\/j.steroids.2023.109330_b0900","doi-asserted-by":"crossref","first-page":"2100381","DOI":"10.1002\/mnfr.202100381","article-title":"Improvement of Non-Alcoholic Fatty Liver Disease in Mice by Intermittent Use of a Fasting-Mimicking Diet","volume":"65","author":"Zhao","year":"2021","journal-title":"Mol. Nutr. Food Res."},{"issue":"10","key":"10.1016\/j.steroids.2023.109330_b0905","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1038\/s42255-021-00469-6","article-title":"Fasting-mimicking diet prevents high-fat diet effect on cardiometabolic risk and lifespan","volume":"3","author":"Mishra","year":"2021","journal-title":"Nat Metab"},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0910","doi-asserted-by":"crossref","first-page":"10599","DOI":"10.1038\/s41598-020-67806-9","article-title":"Author Correction: A Randomised Controlled Trial on the Effectiveness and Adherence of Modified Alternate-day Calorie Restriction in Improving Activity of Non-Alcoholic Fatty Liver Disease","volume":"10","author":"Johari","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.steroids.2023.109330_b0915","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/apt.15063","article-title":"Impact of a structured lifestyle programme on patients with metabolic syndrome complicated by non-alcoholic fatty liver disease","volume":"49","author":"Konerman","year":"2019","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.steroids.2023.109330_b0920","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1248\/bpb.b12-00781","article-title":"Anti-obesity effect of alkaline reduced water in high fat-fed obese mice","volume":"36","author":"Ignacio","year":"2013","journal-title":"Biol. Pharm. Bull."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0925","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1006\/bbrc.1997.6622","article-title":"Electrolyzed-reduced water scavenges active oxygen species and protects DNA from oxidative damage","volume":"234","author":"Shirahata","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.steroids.2023.109330_b0930","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1271\/bbb.70.31","article-title":"Anti-diabetic effect of alkaline-reduced water on OLETF rats","volume":"70","author":"Jin","year":"2006","journal-title":"Biosci. Biotech. Bioch."},{"issue":"8","key":"10.1016\/j.steroids.2023.109330_b0935","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.fct.2009.05.021","article-title":"Hepatoprotective effect of electrolyzed reduced water against carbon tetrachloride-induced liver damage in mice","volume":"47","author":"Tsai","year":"2009","journal-title":"Food Chem. Toxicol."},{"issue":"Suppl 1","key":"10.1016\/j.steroids.2023.109330_b0940","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.33549\/physiolres.933414","article-title":"Preventive and therapeutic application of molecular hydrogen in situations with excessive production of free radicals","volume":"65","author":"Slezak","year":"2016","journal-title":"Physiol. Res."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X23001587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X23001587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:11:45Z","timestamp":1758535905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X23001587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":188,"alternative-id":["S0039128X23001587"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2023.109330","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Navigating nonalcoholic fatty liver disease (NAFLD): Exploring the roles of estrogens, pharmacological and medical interventions, and life style","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2023.109330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109330"}}